Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC): NJLCG0803.
Yosuke Kawashima
No relevant relationships to disclose
Akira Inoue
No relevant relationships to disclose
Shunichi Sugawara
No relevant relationships to disclose
Masao Harada
No relevant relationships to disclose
Kunihiko Kobayashi
No relevant relationships to disclose
Toshiyuki Kozuki
No relevant relationships to disclose
Shoichi Kuyama
No relevant relationships to disclose
Tomohiro Sakakibara
No relevant relationships to disclose
Makoto Maemondo
No relevant relationships to disclose
Hajime Asahina
No relevant relationships to disclose
Akiko Hisamoto
No relevant relationships to disclose
Taku Nakagawa
No relevant relationships to disclose
Toshihiro Nukiwa
No relevant relationships to disclose